U.S. markets closed

ReWalk Robotics Ltd. (RWLK)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3300+0.0400 (+3.10%)
At close: 4:00PM EDT

1.3100 -0.02 (-1.50%)
After hours: 4:24PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close1.2900
Bid1.3100 x 2200
Ask1.3300 x 3100
Day's Range1.3000 - 1.3300
52 Week Range0.4100 - 3.6400
Avg. Volume1,075,546
Market Cap25.455M
Beta (5Y Monthly)3.62
PE Ratio (TTM)N/A
EPS (TTM)-2.0370
Earnings DateAug 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    ReWalk Robotics to Report Second Quarter 2020 Financial Results on August 12, 2020

    MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Aug. 07, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2020 financial results on Wednesday, August 12, 2020, before the U.S. financial markets open. Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will host a conference call to discuss the results as follows:Time8:30 A.M EST Toll free (U.S.)(844) 423-9889 International (U.S)(716) 247-5804 Germany08 00 18 15 287 Israel18 09 31 53 62 Access Code9366548 Webcast (live and replay)https://edge.media-server.com/mmc/p/5i2w4ds5  under the ‘Investors’ section'. The archived webcast will be available via the following https://edge.media-server.com/mmc/p/5i2w4ds5 or through the 'Investors' section' on www.rewalk.com. About ReWalk Robotics Ltd.ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.  ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States. Investor Contact: Ori Gon Chief Financial Officer  ReWalk Robotics Ltd. T: +972-4-9590123  E: investorrelations@rewalk.com

  • ReWalk Robotics (RWLK) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

    ReWalk Robotics (RWLK) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

    ReWalk (RWLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Centers for Medicare & Medicaid Services Issues Code for ReWalk Personal Exoskeleton
    PR Newswire

    Centers for Medicare & Medicaid Services Issues Code for ReWalk Personal Exoskeleton

    ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced the Centers for Medicare and Medicaid Services ("CMS") issued Healthcare Common Procedure Coding System ("HCPCS") Level II Code K1007 in response to the Company's application. This decision, which will be effective on October 1, 2020, establishes the first such code for exoskeletons.